SGCB and Alzheimer disease: As for flavonoids, it remains to be established whether their documented beneficial effects on cognitive functions and in reducing the risk of AD [133] can be attributed, at least in part, to the activation of the NOS/sGC pathway in the cardiovascular and central nervous systems.